![The F-35’s future: What new weapons, systems are coming to the stealth fighter? [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2024/09/8603513-scaled-e1725629281248.jpg?#)
'Hanging on by our fingernails': Stealth CEO questions efficiency behind FDA rejection of rare disease drug
After communicating with the FDA about font sizes for potential packaging on its investigational injection, Stealth Biotherapeutics’ CEO thought approval for the ultrarare genetic disease treatment was imminent.
After communicating with the FDA about font sizes for potential packaging on its investigational injection, Stealth Biotherapeutics’ CEO thought approval for the ultrarare genetic disease treatment was imminent.
